Sharda University and Nanoved Research Foundation have developed HARAS, a nanotechnology-based nutraceutical using curcumin to reduce carbon monoxide levels in smokers’ lungs. Clinical trials demonstrated significant reductions in CO levels, affirming HARAS’s efficacy in protecting smokers’ lung health. This breakthrough offers a promising solution to combat smoking-related diseases, with HARAS available in both liquid and capsule forms for convenient access and integration into treatment plans.
Home » Combatting Smoking Risks: HARAS Nanotech Nutraceutical Offers Hope for Lung Health
Combatting Smoking Risks: HARAS Nanotech Nutraceutical Offers Hope for Lung Health
Facebook
Twitter
LinkedIn
Email
WhatsApp
Facebook
Twitter
LinkedIn
Email
WhatsApp
Related Shorts
Fiber: A Practical Complement to GLP‑1RA Therapy
July 19, 2026
Sprouted Black Chickpeas: Isoflavone-Rich and Bioactive
July 19, 2026
Creatine Supports Brain Health During Menopause
July 19, 2026